Significant Concentrations |
9 Months Ended |
|---|---|
Sep. 30, 2021 | |
| Risks and Uncertainties [Abstract] | |
| Significant Concentrations |
Note 14. Significant Concentrations One customer accounted for approximately 22% and 23% of revenue for the three months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the three months ended September 30, 2021 and 2020. One customer accounted for approximately 23% and 22% of revenue for the nine months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the nine months ended September 30, 2021 and 2020. One vendor accounted for approximately 15% of purchases for the nine months ended September 30, 2021. No other vendors represented more than 10% of purchases for the nine months ended September 30, 2021 and 2020. As of September 30, 2021 and December 31, 2020, one customer accounted for approximately 55% and 32% of accounts receivable, respectively. No other customers represented more than 10% of outstanding accounts receivable as of September 30, 2021 and December 31, 2020. As of September 30, 2021, four vendors accounted for approximately 19%, 12%, 12%, and 11% of accounts payable. As of December 31, 2020, five vendors accounted for approximately 18%, 15%, 15%, 11% and 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of September 30, 2021 and December 31, 2020. |
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|